{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:07:22Z","timestamp":1780556842981,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.seizure.2009.06.009","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T05:12:16Z","timestamp":1248412336000},"page":"607-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model"],"prefix":"10.1016","volume":"18","author":[{"given":"Monika","family":"Dudra-Jastrzebska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M.","family":"Andres-Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville","family":"Ratnaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarogniew J.","family":"Luszczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2009.06.009_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.seizure.2009.06.009_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails: substitution or add-on?","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00003495-198121050-00005","article-title":"Single drug or combination therapy for epilepsy?","volume":"21","author":"Reynolds","year":"1981","journal-title":"Drugs"},{"key":"10.1016\/j.seizure.2009.06.009_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanism of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl. 162","key":"10.1016\/j.seizure.2009.06.009_bib5","first-page":"31","article-title":"Pharmacological principles as a basis for polytherapy","author":"Perucca","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.seizure.2009.06.009_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.seizure.2009.06.009_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.seizure.2009.06.009_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/seiz.2002.0711","article-title":"Seizure freedom with more than one antiepileptic drug","volume":"11","author":"Stephen","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2006.00364.x","article-title":"Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis","volume":"47","author":"Luszczki","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.euroneuro.2005.03.005","article-title":"Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice","volume":"15","author":"Luszczki","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1528-1167.2006.00964.x","article-title":"Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model","volume":"48","author":"Luszczki","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","article-title":"Levetiracetam N01057 Study Group. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy","volume":"69","author":"Berkovic","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2009.06.009_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.seizure.2004.12.006","article-title":"Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study","volume":"14","author":"Alsaadi","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2009.06.009_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-1211(00)00158-3","article-title":"Efficacy and tolerability of 1000\u20134000mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy","volume":"42","author":"Grant","year":"2000","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2006.09.018","article-title":"Levetiracetam monotherapy in children with epilepsy","volume":"36","author":"Khurana","year":"2007","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.seizure.2009.06.009_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0896-6974(96)00010-2","article-title":"Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy","volume":"9","author":"Sharief","year":"1996","journal-title":"Journal of Epilepsy"},{"issue":"Suppl. 7","key":"10.1016\/j.seizure.2009.06.009_bib20","first-page":"179","article-title":"Effect of levetiracetam on resistant juvenile myoclonic epilepsy","volume":"42","author":"Greenhill","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.seizure.2003.06.001","article-title":"Levetiracetam as add-on therapy in generalised epilepsies","volume":"13","author":"Kumar","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2006.05.013","article-title":"Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy","volume":"71","author":"Specchio","year":"2006","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1684\/j.1950-6945.2000.tb00445.x","article-title":"Antimyoclonic effect of levetiracetam","volume":"2","author":"Genton","year":"2000","journal-title":"Epileptic Disorders"},{"key":"10.1016\/j.seizure.2009.06.009_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0920-1211(96)00031-9","article-title":"Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam","volume":"25","author":"Kasteleijn-Nolst Trenite","year":"1996","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib25","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2009.06.009_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1059-1311(03)00193-6","article-title":"Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience","volume":"13","author":"Tan","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(95)00077-1","article-title":"Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy","volume":"22","author":"Gower","year":"1995","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)90855-X","article-title":"Ucb L059 a novel anti-convulsant drug: pharmacological profile in animals","volume":"222","author":"Gower","year":"1992","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"L\u00f6scher","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.seizure.2009.06.009_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90768-D","article-title":"Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats","volume":"232","author":"L\u00f6scher","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2007.05.008","article-title":"Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA\/2J mice","volume":"75","author":"Marrosu","year":"2007","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1528-1167.2008.01594.x","article-title":"Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model","volume":"49","author":"Vinogradova","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.brainresbull.2008.07.006","article-title":"Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats","volume":"77","author":"Margineanu","year":"2008","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.seizure.2009.06.009_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0028-3908(03)00248-X","article-title":"Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?","volume":"45","author":"Madeja","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","article-title":"Selective blockade of N-type calcium channels by levetiracetam","volume":"43","author":"Lukyanetz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices","volume":"306","author":"Niespodziany","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.seizure.2009.06.009_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/seiz.2000.0504","article-title":"Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents","volume":"10","author":"Zona","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib42","doi-asserted-by":"crossref","first-page":"20944","DOI":"10.1073\/pnas.0710522105","article-title":"GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) \u201cphasic\u201d receptors","volume":"104","author":"Palma","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.seizure.2009.06.009_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neulet.2008.02.076","article-title":"Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture","volume":"436","author":"Nagarkatti","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.seizure.2009.06.009_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bcp.2008.04.012","article-title":"PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels","volume":"76","author":"Lee","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib45","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.seizure.2009.06.009_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1059-1311(03)00185-7","article-title":"Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models","volume":"13","author":"Sills","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2009.06.009_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eplepsyres.2004.02.002","article-title":"Anticonvulsant effects of levetiracetam and levetiracetam\u2013diazepam combinations in experimental status epilepticus","volume":"58","author":"Mazarati","year":"2004","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2008.12.046","article-title":"Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis","volume":"605","author":"Dudra-Jastrzebska","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1528-1167.2008.01713.x","article-title":"Benefits of combination therapy in epilepsy: a review of preclinical evidence with levetiracetam","volume":"50","author":"Kaminski","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eplepsyres.2007.04.008","article-title":"Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"75","author":"Donato Di Paola","year":"2007","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00309-6","article-title":"Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction","volume":"48","author":"Sisodiya","year":"2002","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2009.06.009_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2009.06.009_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/1056-8719(95)00025-D","article-title":"Only controls: effect of handling, sham injection, and intraperitoneal injection of saline on behavior of mice in an elevated plus-maze","volume":"34","author":"Lapin","year":"1995","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.seizure.2009.06.009_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.seizure.2009.06.009_bib56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0014-2999(90)90190-H","article-title":"Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction","volume":"179","author":"Porreca","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.seizure.2009.06.009_bib57","series-title":"Drug synergism and dose-effect data analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.seizure.2009.06.009_bib58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00007691-199604000-00008","article-title":"A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography","volume":"18","author":"Ratnaraj","year":"1996","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.seizure.2009.06.009_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle m\u00e9thode simple pour explorer l\u2019action tranquilisante: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"Medicina Experimentalis (Basel)"},{"key":"10.1016\/j.seizure.2009.06.009_bib60","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.seizure.2009.06.009_bib61","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehavioral Toxicology"},{"key":"10.1016\/j.seizure.2009.06.009_bib62","first-page":"1","article-title":"Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions","volume":"13","author":"Patsalos","year":"2004","journal-title":"Reviews in Contemporary Pharmacotherapy"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131109001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131109001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:38:03Z","timestamp":1761010683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131109001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1059131109001356"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2009.06.009","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2009.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}